Enuzovimab

A4DAB105 | Phase-I
SARS-CoV-2 Spike RBD
G4 / None
ABL Bio HiFiBiO Therapeutics
Phase-I
Whole mAb
HFB-3013 HFB3013 HFB30132A HFB-30132A P4A1-2A
—
IMGT PubChem (443565912) PubChem (472422476) PubChem (497622031) PubChem (497623151) Thera-SAbDab YAbS
Avg A4D Score
-0.6312
Score Range
-0.63
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB105_7cjf_A_B 7cjf 100% -0.6312 6.5 4.0 -0.0545 -0.6984